Viewing all links from the source for category: Pharma/Biotech

01/11/2023

Amplia Therapeutics: QUARTERLY ACTIVITIES AND CASH FLOW REPORTS

Starpharma: Quarterly Activities Report & Appendix 4C (ASX Announcement)

4D Medical: Quarterly Activity Report and Appendix 4C for Q1 FY2024

31/10/2023

Pharmaxis: Quarterly Shareholder Update – September 2023

30/10/2023

NeuroScientific Biopharmaceuticals: September 2023 quarterly activity report

4DMedical expands patient access to functional lung imaging with Integral Diagnostics contract

Invion: Notice of Annual General Meeting/Proxy Form

Amplia reports promising clinical data from phase 1B portion of Accent trial in pancreatic cancer

Inoviq: APPENDIX 4C & QUARTERLY BUSINESS UPDATE

20/10/2023

AdAlta: 2023 Annual General Meeting of Shareholders (2023 AGM)

PYC Therapeutics: PYC presenting on PYC-001 program at oligonucleotide therapeutic society 2023 meeting

Patrys: Quarterly activities report and 4C quarterly cash flow report

Imagion: Preliminary Performance of Phase I Study: MagSense® HER2 Imaging Agent

Neuren receives Australian Growth Company of the Year Award

Melodiol: Wholly-owned subsidiary Mernova Medicinal Inc. confirmed POs for October delivery anticipate highest ever monthly revenue following record growth in Q3 FY23

Viralgen welcomes back Andy Holt as CCO

19/10/2023

Clinuvel starts global Phase III vitiligo study

18/10/2023

Noxopharm: mRNA Vaccine Enhancer Shows Significant Inflammation Reduction

Starpharma: Positive DEP® Cabazitaxel Phase 2 Results in Multiple Cancers

Melodiol delivers another record quarter with ~$7.5m in revenue generated during Q3 FY/CY23, up 265% on the PCP

AdAlta: R&D TAX REFUND RECEIVED AND R&D LOAN REPAYMENT TERMS EXTENDED

MAYNE PHARMA PROVIDES UPDATE ON FIRST QUARTER 2024 trading and outlook

17/10/2023

Radiopharm Theranostics: FDA green light for Trivehexin diagnostic Phase 1 pancreatic clinical trial

Orthocell: Quarterly report September 2023`

Kazia Therapeutics: CHANGE OF DATE OF 2023 ANNUAL GENERAL MEETING

Starpharma: DEP irinotecan clinical data presented at AACR meeting (ASX Announcement)

16/10/2023

Melodiol: 100%-owned subsidiary, Health House International generates quarterly net profit of +$300,000 from Australian operations

13/10/2023

Monash University: A well-established drug can improve hand osteoarthritis symptoms: study

AdAlta: ADALTA INVESTOR INFORMATION SESSIONS WITH IPF SURVIVOR BILL VAN NIEROP

TruScreen: Strong Sales Growth in China in Improved Half Year Results

12/10/2023

Melodiol: Wholly-owned subsidiary Halucenex Life Sciences Inc. achieves remission in 80% of first five patients in Phase II clinical trial

CSL avoids strike on remuneration report as investors take board to task on share price fall

11/10/2023

KAZIA ANNOUNCES VOLUNTARY DELISTING FROM ASX

INOVIQ BOARD EXPANDED WITH APPOINTMENT OF DAVID WILLIAMS AS CHAIRMAN

ASX health stocks: Paradigm to seek TGA nod after successful trial; EMVision uses AI simulation

09/10/2023

Radiotherm Theranostics: RAD receives approval for Phase I therapeutic study of PDL1-nanobody in non-small cell lung cancer

Amplia Therapeutics: AACR Ovarian Cancer Conference Presentation

GSK Australia: Australians at risk of shingles have access to a newly funded vaccine

Combination COVID-19/flu vaccines are being tested, with Moderna starting phase 3 trials

05/10/2023

Nutritional Growth Solutions (ASX:NGS) – Walmart Awards Additional Stores, CVS and iHerb Onboarding

Turium.Ai Unveils Zebra: The World’s First Human AI Twin, Elevating Generative AI for Enterprises

04/10/2023

PYC Therapeutics: SECOND DRUG PROGRAM EFFECTIVE IN BOTH NON-HUMAN PRIMATES AND PATIENT-DERIVED MODELS

Ascom Australia Announces New Country Manager

ACCC consults on ACL’s proposed divestiture remedy for Healius acquisition

PHARMAXIS ANNOUNCES MAJOR COMPANY RESTRUCTURE

Careteq Advances Towards FY24 Subscriber Target with ADT New Zealand order

Date of Starpharma’s Annual General Meeting 2023

CSL Seqirus’s cell-based ‘super flu jab’ more effective than conventional vaccines

Cleo Diagnostics Enhances Board Capacity

03/10/2023

Recce Pharmaceuticals: Annual Report 2023